1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Apudoma: new trials by email Literature Review of Apudoma trials Research Report on Apudoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography. - Neuroendocrine, Neuroendocrine Tumor | Phase 1 / Phase 2 | Unknown | Ochsner Health System | 250 | 2014-03-01 | 2014-01-17 |
| 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer 68Ga-DOTATATE PET scan - Neuroendocrine Carcinoma | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 97 | 2010-03-01 | 2016-03-29 |
Adenoma, Islet Cell (2) · Carcinoid Tumor (2) · Carcinoma, Neuroendocrine (2) · Neuroendocrine Tumors (2)
Adenocarcinoma (2) · Adenoma (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Pancreatic Diseases (2)
Ochsner Health System (1) · Vanderbilt-Ingram Cancer Center (1)
United States (2)